Industry Standards

International Data Security Certifications

At Neopharma Technologies, we are committed to maintaining the highest levels of data security, privacy and compliance. Our adherence to key international certifications and standards aligns with our commitment to protecting our clients' sensitive information and maintaining their trust by meeting the highest international standard for security, privacy, and regulatory compliance.

ISO 27001

The ISO 27001 certification confirms Neopharma's adherence to global best practices for Information Security Management Systems (ISMS). This ensures that all information is protected according to the highest international standards.

ISO 42001

ISO/IEC 42001 certification confirms Neopharma manages its AI responsibly, with risk and impact assessment, transparency, data quality controls and human oversight across the life of its AI systems, including NEO-Vision result reading.

EU Compliant

GDPR compliance confirms that Neopharma meets strict global standards for data protection, privacy, and security across its systems.

SOC 2 Type 2

Our SOC 2 Type 2 report independently attests that Neopharma processes and protects customer data securely and privately, based on the Trust Services Criteria.

HIPAA

Aligned with HIPAA safeguards, so medical and patient data is handled securely and in line with US federal requirements for healthcare data protection.

Professional Industry Body Memberships and Associations

Neopharma maintains memberships with several leading industry bodies and organizations globally. This keeps us current with industry trends and developments, and allows us to share our insights with other professionals in our field.

NDASA is dedicated to the safety, legal, and regulatory integrity of the drug and alcohol testing industry. As members, Neopharma follows the latest industry trends, regulatory changes, and professional guidelines, ensuring we are at the forefront of the industry to better help our clients with their testing needs and workplace safety.

SAPAA mission is to provide education, resources, and advocacy for companies, organizations and individuals involved in the drug and alcohol testing industry. SAPAA focuses on the promotion of professional standards and best practices for the drug and alcohol testing industry. As members, Neopharma remains current on the many aspects of testing, including but not limited to federal regulations, collection procedures, and MRO role.

WDTA is a new industry body for the coal extracting, mining products, and mineral processing industries in Australia. The WDTA represents the collective interests of the Australian drug testing sector in Australia. As an early member, Neopharma is proud to contribute to a common and agreed quality framework that support professional drug testing practices into the future with high standards of professional practice.

Neopharma believes that combining technology and psychology provides the strongest path forward for the employer and their employees in workplaces to promote workplace safety. Psychology and technology intersect to solve problems related to drug and alcohol testing.